New Delhi, Aug. 10 -- The Molbio Diagnostics IPO, with a price band of Rs.768-807 per share, will open for public subscription on August 10 and close on August 12. The initial share sale is estimated to raise between Rs.904 crore and Rs.940 crore at the lower and upper ends of the price band, respectively.

The point-of-care diagnostics company, backed by Temasek and Motilal Oswal Private Equity, has already raised Rs.281.5 crore from anchor investors ahead of the IPO. The company allotted 34.88 lakh equity shares to 33 anchor investors at Rs.807 per share, the upper end of the price band.

The anchor book saw participation from leading investors including Goldman Sachs, BlackRock Global Funds, Mirae Asset, Nippon India Mutual Fund, ICICI...